Tradestie Institutional Equity Comparison Engine

HAO vs GXC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HAO Overall Edge

HAO Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Haoxi Health Technology Limited Class A Ordinary Shares (HAO) driven by superior Growth & Margin, Momentum & Technical while GXC counters with relative strength in Options & Structure. Fundamentally, HAO trades at N/M Forward P/E with -14.9% operating margin (+137.3% YoY revenue) versus GXC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HAO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GXC sits in UNCLASSIFIED (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
HAO N/M vs GXC N/M Fwd P/E
Growth & Margin Winner HAO
Op Margin -14.9% vs N/A ยท YoY +137.3% vs N/A
Momentum & Technical Winner HAO
1Y +112.5% vs -22.2% ยท 52W Pos 36% vs 0%
Options & Structure Winner GXC
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (8th %ile IV)
HAO NASDAQ
Haoxi Health Technology Limited Class A Ordinary Shares
Services-Advertising Agencies
$2.00
-4.09% 1D
Market Cap $1.3M
1M Return -5.45%
1Y Return +112.46%
Forward P/E N/M
Unified AI Score
55.9 / 100 HOLD
Tech 70.0 Fund 45.0 Flow 50.0 Mom 58.9
GXC NYSE Arca
SPDR S&P China ETF
Institutional Equity
$80.19
-1.14% 1D
Market Cap N/A
1M Return -4.58%
1Y Return -22.22%
Forward P/E N/M
Unified AI Score
39.5 / 100 SELL
Tech 34.0 Fund 50.0 Flow 50.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HAO +112.46% GXC -22.22% Spread: +142.18 pp (HAO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HAO TTM Op. Margin: -14.9% GXC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HAO vs GXC. Trailing 12-month operating profitability (HAO -14.9% vs GXC N/A) and valuation multiples (HAO N/M vs GXC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HAO (7) vs GXC (1)
Institutional Metric HAO GXC Criterion Row Winner
Market Capitalization Scale $1.3M N/A Larger Scale HAO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +137.3% N/A Higher Growth HAO
Operating Margin (TTM) Profitability -14.9% N/A Higher Margin HAO
Net Profit Margin Profitability -17.4% N/A Higher Margin HAO
Return on Equity (ROE) Capital Efficiency -54.1% N/A Higher ROE HAO
52-Week Range Position Momentum 36% ($0โ€“$5) 0% ($80โ€“$105) Stronger Trend HAO
Beta / 30D Volatility Risk Regime 7.50ฮฒ ยท 151% Vol 0.65ฮฒ ยท 20% Vol Lower Realized Risk GXC
Unified Institutional Score Composite Signal 55.9 / 100 (HOLD) 39.5 / 100 (SELL) Higher Composite HAO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HAO vs GXC Buy Guide
HAO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HAO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GXC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live GXC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HAO nor GXC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.